Mitoimmune Therapeutics

Provides drug development for treating mitochondrial dysfunction

placeSeoul, Seoul, South Korea calendar_todayFounded 2018 groups16 employees language mitoimmune.com

Mito Immune Therapeutics Co., Ltd.

Reg. No. 350-87-01166South Korea

14 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating.

Coming soon